Skip to main content
Erschienen in: Cellular Oncology 1/2018

13.11.2017 | Original Paper

Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion

verfasst von: Kamdeo K. Pramanik, Siddavaram Nagini, Abhay K. Singh, Prajna Mishra, Tanushree Kashyap, Nidhi Nath, Manzar Alam, Ajay Rana, Rajakishore Mishra

Erschienen in: Cellular Oncology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Oral squamous cell carcinoma (OSCC)-related deaths mainly result from invasion of the tumor cells into local cervical lymph nodes. It has been reported that progressive basement membrane loss promotes the metastatic and invasive capacities of OSCCs. Matrix metalloproteinase-9 (MMP-9) is known to play a central role in tumor progression and invasion. However, the role of MMP-9 in OSCC invasion has so far remained paradoxical and little is known about its regulation. Here, we aimed to assess MMP-9 expression regulation and its activation by glycogen synthase kinase-3β during human OSCC progression and invasion.

Methods

In the present study, 178 human OSCC samples, including 118 fresh samples (18 adjacent normal, 42 noninvasive and 58 invasive tumor samples) and 60 archival human tissue microarray (TMA) tongue cancer samples, were included. mRNA expression, protein expression, MMP-9/-2 activity, protein-protein interaction and Snail, c-Myc, β-catenin and TIMP1 expression were assessed using RT-PCR, immunohistochemistry, Western blotting, co-immunoprecipitation and gelatin zymography analyses, respectively. Wnt5a and LPA mediated MMP-9 regulation was assessed in OCSCC-derived SCC-9 cells exogenously expressing GSK3β (WT) or non phosphoryable GSK3β (S9A).

Results

We observed a progressive up-regulation/activation of MMP-9 at various stages of oral tumor progression/invasion. Positive correlations were observed between MMP-9 and c-Myc expression, MMP-9 and MMP-2 activity, MMP-9 and TIMP1 expression and MMP-9 activity and TIMP1-MMP-9 interaction. In contrast, a negative correlation between phosphorylated β-catenin and MMP-9 expression was observed. Conversely, we found that in oral tongue SCC MMP-9 expression was positively correlated with inactivation of GSK3 signaling. Finally, we found that Wnt5a and LPA mediated increased MMP-9 and decreased GSK3β activities in tongue SCC-derived SCC-9 cells. MMP-9 regulation by GSK3β was confirmed by using phosphoryable/regulatory GSK3β (WT construct) and not by non-phosphoryable GSK3β (S9A construct).

Conclusions

Collectively, our results show that MMP-9 overexpression and activation are important events occurring during OSCC progression/invasion and that this overexpression/activation is regulated by c-Myc, active MMP-2 and inactive GSK3β mediated pathways.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat J. Noguti, C.F. De Moura, G.P. De Jesus, V.H. Da Silva, T.A. Hossaka, C.T. Oshima, D.A. Ribeiro, Metastasis from oral cancer: An overview. Cancer Genomics Proteomics 9, 329–335 (2012)PubMed J. Noguti, C.F. De Moura, G.P. De Jesus, V.H. Da Silva, T.A. Hossaka, C.T. Oshima, D.A. Ribeiro, Metastasis from oral cancer: An overview. Cancer Genomics Proteomics 9, 329–335 (2012)PubMed
2.
Zurück zum Zitat L. Jimenez, S.K. Jayakar, T.J. Ow, J.E. Segall, Mechanisms of invasion in head and neck cancer. Arch Pathol Lab Med 139, 1334–1348 (2015)CrossRefPubMed L. Jimenez, S.K. Jayakar, T.J. Ow, J.E. Segall, Mechanisms of invasion in head and neck cancer. Arch Pathol Lab Med 139, 1334–1348 (2015)CrossRefPubMed
3.
Zurück zum Zitat M.B. Duz, O.F. Karatas, E. Guzel, N.F. Turgut, M. Yilmaz, C.J. Creighton, M. Ozen, Identification of mir-139-5p as a saliva biomarker for tongue squamous cell carcinoma: A pilot study. Cell Oncol 39, 187–193 (2016)CrossRef M.B. Duz, O.F. Karatas, E. Guzel, N.F. Turgut, M. Yilmaz, C.J. Creighton, M. Ozen, Identification of mir-139-5p as a saliva biomarker for tongue squamous cell carcinoma: A pilot study. Cell Oncol 39, 187–193 (2016)CrossRef
4.
Zurück zum Zitat B. Jang, J.-A. Shin, Y.-S. Kim, J.-Y. Kim, H.-K. Yi, I.-S. Park, N.-P. Cho, S.-D. Cho, Growth-suppressive effect of suberoylanilide hydroxamic acid (saha) on human oral cancer cells. Cell Oncol 39, 79–87 (2016)CrossRef B. Jang, J.-A. Shin, Y.-S. Kim, J.-Y. Kim, H.-K. Yi, I.-S. Park, N.-P. Cho, S.-D. Cho, Growth-suppressive effect of suberoylanilide hydroxamic acid (saha) on human oral cancer cells. Cell Oncol 39, 79–87 (2016)CrossRef
5.
Zurück zum Zitat M.A. St John, G. Wang, J. Luo, M. Dohadwala, D. Hu, Y. Lin, M. Dennis, J.M. Lee, D. Elashoff, T. Lawhon, S.L. Zaknoen, F.J. Burrows, S.M. Dubinett, Apricoxib upregulates 15-pgdh and pgt in tobacco-related epithelial malignancies. Br J Cancer 107, 707–712 (2012)CrossRefPubMedCentralPubMed M.A. St John, G. Wang, J. Luo, M. Dohadwala, D. Hu, Y. Lin, M. Dennis, J.M. Lee, D. Elashoff, T. Lawhon, S.L. Zaknoen, F.J. Burrows, S.M. Dubinett, Apricoxib upregulates 15-pgdh and pgt in tobacco-related epithelial malignancies. Br J Cancer 107, 707–712 (2012)CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat D. Hanahan, R.A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646–674 (2011)CrossRefPubMed D. Hanahan, R.A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646–674 (2011)CrossRefPubMed
7.
Zurück zum Zitat C.R. Leemans, B.J. Braakhuis, R.H. Brakenhoff, The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9–22 (2010)CrossRefPubMed C.R. Leemans, B.J. Braakhuis, R.H. Brakenhoff, The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9–22 (2010)CrossRefPubMed
9.
Zurück zum Zitat J.E. Rundhaug, Matrix metalloproteinases, Angiogenesis, and cancer: Commentary re: A C Lockhart et al, reduction of wound angiogenesis in patients treated with bms-275291, a broad spectrum matrix metalloproteinase inhibitor Clin Cancer res, 9: 00–00, 2003 Clin Cancer Res 9, 551–554 (2003) J.E. Rundhaug, Matrix metalloproteinases, Angiogenesis, and cancer: Commentary re: A C Lockhart et al, reduction of wound angiogenesis in patients treated with bms-275291, a broad spectrum matrix metalloproteinase inhibitor Clin Cancer res, 9: 00–00, 2003 Clin Cancer Res 9, 551–554 (2003)
10.
Zurück zum Zitat B.P. Patel, S.V. Shah, S.N. Shukla, P.M. Shah, P.S. Patel, Clinical significance of mmp-2 and mmp-9 in patients with oral cancer. Head Neck 29, 564–572 (2007)CrossRefPubMed B.P. Patel, S.V. Shah, S.N. Shukla, P.M. Shah, P.S. Patel, Clinical significance of mmp-2 and mmp-9 in patients with oral cancer. Head Neck 29, 564–572 (2007)CrossRefPubMed
11.
Zurück zum Zitat J.C. de Vicente, M.F. Fresno, L. Villalain, J.A. Vega, G. Hernandez Vallejo, Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41, 283–293 (2005)CrossRefPubMed J.C. de Vicente, M.F. Fresno, L. Villalain, J.A. Vega, G. Hernandez Vallejo, Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41, 283–293 (2005)CrossRefPubMed
12.
Zurück zum Zitat M. Aparna, L. Rao, V. Kunhikatta, R. Radhakrishnan, The role of mmp-2 and mmp-9 as prognostic markers in the early stages of tongue squamous cell carcinoma. J Oral Pathol Med 44, 345–352 (2015)CrossRefPubMed M. Aparna, L. Rao, V. Kunhikatta, R. Radhakrishnan, The role of mmp-2 and mmp-9 as prognostic markers in the early stages of tongue squamous cell carcinoma. J Oral Pathol Med 44, 345–352 (2015)CrossRefPubMed
13.
Zurück zum Zitat L.K. Makinen, V. Hayry, T. Atula, C. Haglund, H. Keski-Santti, I. Leivo, A. Makitie, F. Passador-Santos, C. Bockelman, T. Salo, T. Sorsa, J. Hagstrom, Prognostic significance of matrix metalloproteinase-2, −8, −9, and −13 in oral tongue cancer. J Oral Pathol Med 41, 394–399 (2011)CrossRefPubMed L.K. Makinen, V. Hayry, T. Atula, C. Haglund, H. Keski-Santti, I. Leivo, A. Makitie, F. Passador-Santos, C. Bockelman, T. Salo, T. Sorsa, J. Hagstrom, Prognostic significance of matrix metalloproteinase-2, −8, −9, and −13 in oral tongue cancer. J Oral Pathol Med 41, 394–399 (2011)CrossRefPubMed
14.
Zurück zum Zitat S.S. Barros, A.C. Henriques, K.M. Pereira, A.M. de Medeiros, H.C. Galvao, A. Freitas Rde, Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip. Arch Oral Biol 56, 752–760 (2011)CrossRefPubMed S.S. Barros, A.C. Henriques, K.M. Pereira, A.M. de Medeiros, H.C. Galvao, A. Freitas Rde, Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip. Arch Oral Biol 56, 752–760 (2011)CrossRefPubMed
15.
Zurück zum Zitat L.M. Coussens, B. Fingleton, L.M. Matrisian, Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295, 2387–2392 (2002)CrossRefPubMed L.M. Coussens, B. Fingleton, L.M. Matrisian, Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295, 2387–2392 (2002)CrossRefPubMed
16.
Zurück zum Zitat D. Guttman, Y. Stern, T. Shpitzer, D. Ulanovski, T. Druzd, R. Feinmesser, Expression of mmp-9, timp-1, cd-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol 40, 798–803 (2004)CrossRefPubMed D. Guttman, Y. Stern, T. Shpitzer, D. Ulanovski, T. Druzd, R. Feinmesser, Expression of mmp-9, timp-1, cd-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol 40, 798–803 (2004)CrossRefPubMed
17.
Zurück zum Zitat B. Qiao, N.W. Johnson, J. Gao, Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions. Int J Oncol 37, 663–668 (2010)PubMed B. Qiao, N.W. Johnson, J. Gao, Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions. Int J Oncol 37, 663–668 (2010)PubMed
19.
Zurück zum Zitat R. Mishra, S. Nagini, A. Rana, Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin d1 and p53 in oral squamous cell carcinoma progression. Mol Cancer 14, 20 (2015)CrossRefPubMedCentralPubMed R. Mishra, S. Nagini, A. Rana, Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin d1 and p53 in oral squamous cell carcinoma progression. Mol Cancer 14, 20 (2015)CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat G.R. Yedida, S. Nagini, R. Mishra, The importance of oncogenic transcription factors for oral cancer pathogenesis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 116, 179–188 (2013)CrossRefPubMed G.R. Yedida, S. Nagini, R. Mishra, The importance of oncogenic transcription factors for oral cancer pathogenesis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 116, 179–188 (2013)CrossRefPubMed
21.
Zurück zum Zitat E. Batlle, E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, A. Garcia De Herreros, The transcription factor snail is a repressor of e-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84–89 (2000)CrossRefPubMed E. Batlle, E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, A. Garcia De Herreros, The transcription factor snail is a repressor of e-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84–89 (2000)CrossRefPubMed
22.
Zurück zum Zitat B.P. Zhou, J. Deng, W. Xia, J. Xu, Y.M. Li, M. Gunduz, M.C. Hung, Dual regulation of snail by gsk-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6, 931–940 (2004)CrossRefPubMed B.P. Zhou, J. Deng, W. Xia, J. Xu, Y.M. Li, M. Gunduz, M.C. Hung, Dual regulation of snail by gsk-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6, 931–940 (2004)CrossRefPubMed
23.
Zurück zum Zitat Z. Prgomet, L. Axelsson, P. Lindberg, T. Andersson, Migration and invasion of oral squamous carcinoma cells is promoted by wnt5a, a regulator of cancer progression. J Oral Pathol Med 44, 776–784 (2015)CrossRefPubMed Z. Prgomet, L. Axelsson, P. Lindberg, T. Andersson, Migration and invasion of oral squamous carcinoma cells is promoted by wnt5a, a regulator of cancer progression. J Oral Pathol Med 44, 776–784 (2015)CrossRefPubMed
24.
Zurück zum Zitat N. Bhattacharya, A. Roy, B. Roy, S. Roychoudhury, C.K. Panda, Myc gene amplification reveals clinical association with head and neck squamous cell carcinoma in indian patients. J Oral Pathol Med 38, 759–763 (2009)CrossRefPubMed N. Bhattacharya, A. Roy, B. Roy, S. Roychoudhury, C.K. Panda, Myc gene amplification reveals clinical association with head and neck squamous cell carcinoma in indian patients. J Oral Pathol Med 38, 759–763 (2009)CrossRefPubMed
25.
Zurück zum Zitat R. Mishra, B.R. Das, Early overexpression of cdk4 and possible role of krf and c-myc in chewing tobacco mediated oral cancer development. Mol Biol Rep 30, 207–213 (2003)CrossRefPubMed R. Mishra, B.R. Das, Early overexpression of cdk4 and possible role of krf and c-myc in chewing tobacco mediated oral cancer development. Mol Biol Rep 30, 207–213 (2003)CrossRefPubMed
26.
Zurück zum Zitat R. Fridman, M. Toth, D. Pena, S. Mobashery, Activation of progelatinase b (mmp-9) by gelatinase a (mmp-2). Cancer Res 55, 2548–2555 (1995)PubMed R. Fridman, M. Toth, D. Pena, S. Mobashery, Activation of progelatinase b (mmp-9) by gelatinase a (mmp-2). Cancer Res 55, 2548–2555 (1995)PubMed
27.
Zurück zum Zitat I.J. Brusevold, I.H. Tveteraas, M. Aasrum, J. Ødegård, D.L. Sandnes, T. Christoffersen, 516: Role of lpar3, pkc and egfr in lpa-induced cell migration in oral squamous carcinoma cells. Eur J Cancer S124 (2014) I.J. Brusevold, I.H. Tveteraas, M. Aasrum, J. Ødegård, D.L. Sandnes, T. Christoffersen, 516: Role of lpar3, pkc and egfr in lpa-induced cell migration in oral squamous carcinoma cells. Eur J Cancer S124 (2014)
28.
Zurück zum Zitat J.A. Lorenzo, C.C. Pilbeam, J.F. Kalinowski, M.S. Hibbs, Production of both 92- and 72-kda gelatinases by bone cells. Matrix 12, 282–290 (1992)CrossRefPubMed J.A. Lorenzo, C.C. Pilbeam, J.F. Kalinowski, M.S. Hibbs, Production of both 92- and 72-kda gelatinases by bone cells. Matrix 12, 282–290 (1992)CrossRefPubMed
29.
Zurück zum Zitat K.K. Pramanik, A.K. Singh, M. Alam, T. Kashyap, P. Mishra, A.K. Panda, R.K. Dey, A. Rana, S. Nagini, R. Mishra, Reversion-inducing cysteine-rich protein with kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer. Tumor Biol 37, 15253–15264 (2016)CrossRef K.K. Pramanik, A.K. Singh, M. Alam, T. Kashyap, P. Mishra, A.K. Panda, R.K. Dey, A. Rana, S. Nagini, R. Mishra, Reversion-inducing cysteine-rich protein with kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer. Tumor Biol 37, 15253–15264 (2016)CrossRef
30.
Zurück zum Zitat S. Mukhopadhyay, H.G. Munshi, S. Kambhampati, A. Sassano, L.C. Platanias, M.S. Stack, Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by erk1/2 and p38 mapk in oral keratinocytes and oral squamous cell carcinoma. J Biol Chem 279, 33139–33146 (2004)CrossRefPubMed S. Mukhopadhyay, H.G. Munshi, S. Kambhampati, A. Sassano, L.C. Platanias, M.S. Stack, Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by erk1/2 and p38 mapk in oral keratinocytes and oral squamous cell carcinoma. J Biol Chem 279, 33139–33146 (2004)CrossRefPubMed
31.
Zurück zum Zitat S.T. Vilen, T. Salo, T. Sorsa, P. Nyberg, Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal 2013, 920595 (2013)CrossRefPubMedCentralPubMed S.T. Vilen, T. Salo, T. Sorsa, P. Nyberg, Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal 2013, 920595 (2013)CrossRefPubMedCentralPubMed
32.
Zurück zum Zitat K.U. Ogbureke, P.M. Weinberger, S.W. Looney, L. Li, L.W. Fisher, Expressions of matrix metalloproteinase-9 (mmp-9), dentin sialophosphoprotein (dspp), and osteopontin (opn) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma. Oncotarget 3, 286–298 (2012)CrossRefPubMedCentralPubMed K.U. Ogbureke, P.M. Weinberger, S.W. Looney, L. Li, L.W. Fisher, Expressions of matrix metalloproteinase-9 (mmp-9), dentin sialophosphoprotein (dspp), and osteopontin (opn) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma. Oncotarget 3, 286–298 (2012)CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat E.S. Nakamura, K. Koizumi, M. Kobayashi, I. Saiki, Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor mmi270. Cancer Sci 95, 25–31 (2004)CrossRefPubMed E.S. Nakamura, K. Koizumi, M. Kobayashi, I. Saiki, Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor mmi270. Cancer Sci 95, 25–31 (2004)CrossRefPubMed
34.
Zurück zum Zitat R. Paduch, The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol 39, 397–410 (2016)CrossRef R. Paduch, The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol 39, 397–410 (2016)CrossRef
35.
Zurück zum Zitat K.W. Min, S.H. Lee, S.J. Baek, Moonlighting proteins in cancer. Cancer Lett 370, 108–116 (2016)CrossRefPubMed K.W. Min, S.H. Lee, S.J. Baek, Moonlighting proteins in cancer. Cancer Lett 370, 108–116 (2016)CrossRefPubMed
36.
Zurück zum Zitat L. Li, H. Li, Role of microrna-mediated mmp regulation in the treatment and diagnosis of malignant tumors. Cancer biology & therapy 14, 796–805 (2013)CrossRef L. Li, H. Li, Role of microrna-mediated mmp regulation in the treatment and diagnosis of malignant tumors. Cancer biology & therapy 14, 796–805 (2013)CrossRef
37.
Zurück zum Zitat K. Si-Tayeb, A. Monvoisin, C. Mazzocco, S. Lepreux, M. Decossas, G.l. Cubel, D.l. Taras, J.-F. Blanc, D.R. Robinson, J. Rosenbaum, Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 169, 1390–1401 (2006) K. Si-Tayeb, A. Monvoisin, C. Mazzocco, S. Lepreux, M. Decossas, G.l. Cubel, D.l. Taras, J.-F. Blanc, D.R. Robinson, J. Rosenbaum, Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 169, 1390–1401 (2006)
38.
Zurück zum Zitat J.A. Kwan, C.J. Schulze, W. Wang, H. Leon, M. Sariahmetoglu, M. Sung, J. Sawicka, D.E. Sims, G. Sawicki, R. Schulz, Matrix metalloproteinase-2 (mmp-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (adp-ribose) polymerase (parp) in vitro. FASEB J 18, 690–692 (2004)CrossRefPubMed J.A. Kwan, C.J. Schulze, W. Wang, H. Leon, M. Sariahmetoglu, M. Sung, J. Sawicka, D.E. Sims, G. Sawicki, R. Schulz, Matrix metalloproteinase-2 (mmp-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (adp-ribose) polymerase (parp) in vitro. FASEB J 18, 690–692 (2004)CrossRefPubMed
39.
Zurück zum Zitat D.J. Marchant, C.L. Bellac, T.J. Moraes, S.J. Wadsworth, A. Dufour, G.S. Butler, L.M. Bilawchuk, R.G. Hendry, A.G. Robertson, C.T. Cheung, A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nat Med 20, 493–502 (2014)CrossRefPubMed D.J. Marchant, C.L. Bellac, T.J. Moraes, S.J. Wadsworth, A. Dufour, G.S. Butler, L.M. Bilawchuk, R.G. Hendry, A.G. Robertson, C.T. Cheung, A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nat Med 20, 493–502 (2014)CrossRefPubMed
40.
Zurück zum Zitat M.A. Moles, J.A. Montoya, M.D. Salvago, I.R. Avila, J.J. Campillo, M. Bravo, Implications of differential expression of beta-catenin in oral carcinoma. Anticancer Res 36, 1599–1604 (2016)PubMed M.A. Moles, J.A. Montoya, M.D. Salvago, I.R. Avila, J.J. Campillo, M. Bravo, Implications of differential expression of beta-catenin in oral carcinoma. Anticancer Res 36, 1599–1604 (2016)PubMed
41.
Zurück zum Zitat T. Hu, Y.R. Lu, Bcyrn1, a c-myc-activated long non-coding rna, regulates cell metastasis of non-small-cell lung cancer. Cancer Cell Int 15, 36 (2015)CrossRefPubMedCentralPubMed T. Hu, Y.R. Lu, Bcyrn1, a c-myc-activated long non-coding rna, regulates cell metastasis of non-small-cell lung cancer. Cancer Cell Int 15, 36 (2015)CrossRefPubMedCentralPubMed
42.
Zurück zum Zitat Y. Song, Q.X. Yang, F. Zhang, F. Meng, H. Li, Y. Dong, A. Han, Suppression of nasopharyngeal carcinoma cell by targeting beta-catenin signaling pathway. Cancer Epidemiol 36, e116–e121 (2012)CrossRefPubMed Y. Song, Q.X. Yang, F. Zhang, F. Meng, H. Li, Y. Dong, A. Han, Suppression of nasopharyngeal carcinoma cell by targeting beta-catenin signaling pathway. Cancer Epidemiol 36, e116–e121 (2012)CrossRefPubMed
43.
Zurück zum Zitat J. Lian, J. Tang, H. Shi, H. Li, T. Zhen, W. Xie, F. Zhang, Y. Yang, A. Han, Positive feedback loop of hepatoma-derived growth factor and beta-catenin promotes carcinogenesis of colorectal cancer. Oncotarget 6, 29357–29374 (2015)PubMedCentralPubMed J. Lian, J. Tang, H. Shi, H. Li, T. Zhen, W. Xie, F. Zhang, Y. Yang, A. Han, Positive feedback loop of hepatoma-derived growth factor and beta-catenin promotes carcinogenesis of colorectal cancer. Oncotarget 6, 29357–29374 (2015)PubMedCentralPubMed
44.
Zurück zum Zitat T. Zhen, S. Dai, H. Li, Y. Yang, L. Kang, H. Shi, F. Zhang, D. Yang, S. Cai, Y. He, Y. Liang, A. Han, Macc1 promotes carcinogenesis of colorectal cancer via beta-catenin signaling pathway. Oncotarget 5, 3756–3769 (2014)CrossRefPubMedCentralPubMed T. Zhen, S. Dai, H. Li, Y. Yang, L. Kang, H. Shi, F. Zhang, D. Yang, S. Cai, Y. He, Y. Liang, A. Han, Macc1 promotes carcinogenesis of colorectal cancer via beta-catenin signaling pathway. Oncotarget 5, 3756–3769 (2014)CrossRefPubMedCentralPubMed
45.
Zurück zum Zitat L. Sun, M.E. Diamond, A.J. Ottaviano, M.J. Joseph, V. Ananthanarayan, H.G. Munshi, Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol Cancer Res 6, 10–20 (2008)CrossRefPubMed L. Sun, M.E. Diamond, A.J. Ottaviano, M.J. Joseph, V. Ananthanarayan, H.G. Munshi, Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol Cancer Res 6, 10–20 (2008)CrossRefPubMed
47.
Zurück zum Zitat M. Perez-Sayans Garcia, J.M. Suarez-Penaranda, P. Gayoso-Diz, F. Barros-Angueira, J.M. Gandara-Rey, A. Garcia-Garcia, Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target? Cancer Lett 323, 11–19 (2012)CrossRefPubMed M. Perez-Sayans Garcia, J.M. Suarez-Penaranda, P. Gayoso-Diz, F. Barros-Angueira, J.M. Gandara-Rey, A. Garcia-Garcia, Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target? Cancer Lett 323, 11–19 (2012)CrossRefPubMed
48.
Zurück zum Zitat C. Ondruschka, P. Buhtz, C. Motsch, B. Freigang, R. Schneider-Stock, A. Roessner, C. Boltze, Prognostic value of mmp-2, −9 and timp-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas. Pathol Res Pract 198, 509–515 (2002)CrossRefPubMed C. Ondruschka, P. Buhtz, C. Motsch, B. Freigang, R. Schneider-Stock, A. Roessner, C. Boltze, Prognostic value of mmp-2, −9 and timp-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas. Pathol Res Pract 198, 509–515 (2002)CrossRefPubMed
49.
Zurück zum Zitat T. Yoshizaki, Y. Maruyama, H. Sato, M. Furukawa, Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 95, 44–50 (2001)CrossRefPubMed T. Yoshizaki, Y. Maruyama, H. Sato, M. Furukawa, Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 95, 44–50 (2001)CrossRefPubMed
50.
Zurück zum Zitat R. Lander, T. Nasr, S.D. Ochoa, K. Nordin, M.S. Prasad, C. Labonne, Interactions between twist and other core epithelial-mesenchymal transition factors are controlled by gsk3-mediated phosphorylation. Nat Commun 4, 1542 (2013)CrossRefPubMedCentralPubMed R. Lander, T. Nasr, S.D. Ochoa, K. Nordin, M.S. Prasad, C. Labonne, Interactions between twist and other core epithelial-mesenchymal transition factors are controlled by gsk3-mediated phosphorylation. Nat Commun 4, 1542 (2013)CrossRefPubMedCentralPubMed
51.
Zurück zum Zitat L. Zheng, N. Li, F. Guo, X.C. Jian, C.H. Jiang, P. Yin, A.J. Min, L. Huang, Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through beta-catenin signaling. Mol Med Rep 11, 2255–2261 (2015)CrossRefPubMed L. Zheng, N. Li, F. Guo, X.C. Jian, C.H. Jiang, P. Yin, A.J. Min, L. Huang, Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through beta-catenin signaling. Mol Med Rep 11, 2255–2261 (2015)CrossRefPubMed
52.
Zurück zum Zitat C. Takahashi, Z. Sheng, T.P. Horan, H. Kitayama, M. Maki, K. Hitomi, Y. Kitaura, S. Takai, R.M. Sasahara, A. Horimoto, Y. Ikawa, B.J. Ratzkin, T. Arakawa, M. Noda, Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein reck. Proc Natl Acad Sci U S A 95, 13221–13226 (1998)CrossRefPubMedCentralPubMed C. Takahashi, Z. Sheng, T.P. Horan, H. Kitayama, M. Maki, K. Hitomi, Y. Kitaura, S. Takai, R.M. Sasahara, A. Horimoto, Y. Ikawa, B.J. Ratzkin, T. Arakawa, M. Noda, Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein reck. Proc Natl Acad Sci U S A 95, 13221–13226 (1998)CrossRefPubMedCentralPubMed
53.
Zurück zum Zitat S.L. Dallas, J.L. Rosser, G.R. Mundy, L.F. Bonewald, Proteolysis of latent transforming growth factor-beta (tgf-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of tgf-beta from bone matrix. J Biol Chem 277, 21352–21360 (2002)CrossRefPubMed S.L. Dallas, J.L. Rosser, G.R. Mundy, L.F. Bonewald, Proteolysis of latent transforming growth factor-beta (tgf-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of tgf-beta from bone matrix. J Biol Chem 277, 21352–21360 (2002)CrossRefPubMed
54.
Zurück zum Zitat K.D. Cowden Dahl, J. Symowicz, Y. Ning, E. Gutierrez, D.A. Fishman, B.P. Adley, M.S. Stack, L.G. Hudson, Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 68, 4606–4613 (2008)CrossRefPubMedCentralPubMed K.D. Cowden Dahl, J. Symowicz, Y. Ning, E. Gutierrez, D.A. Fishman, B.P. Adley, M.S. Stack, L.G. Hudson, Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 68, 4606–4613 (2008)CrossRefPubMedCentralPubMed
Metadaten
Titel
Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion
verfasst von
Kamdeo K. Pramanik
Siddavaram Nagini
Abhay K. Singh
Prajna Mishra
Tanushree Kashyap
Nidhi Nath
Manzar Alam
Ajay Rana
Rajakishore Mishra
Publikationsdatum
13.11.2017
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 1/2018
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-017-0358-0

Weitere Artikel der Ausgabe 1/2018

Cellular Oncology 1/2018 Zur Ausgabe

Letter to the Editor

Metabolic iodine and tumours

Neu im Fachgebiet Pathologie